Apr 1, 2026
Apr 1, 2026
Apr 1, 2026
Apr 1, 2026
Apr 1, 2026
Apr 1, 2026
Apr 1, 2026
Apr 1, 2026
Axsome Therapeutics, a lesser-known biotech firm, has outperformed broader equities over the past five years. This article examines why a $10,000 investment now could lead to substantial returns by 2036.